Lung Cancer Trial, Recruiting NCT03706027 Sponsor: University of Rochester Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT03706027
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a type of non-small cell lung cancer, such as squamous cell carcinoma, adenocarcinoma, large cell carcinoma, bronchioalveolar carcinoma, or a similar type.
  • Your cancer is at an early stage, specifically classified as T1 N0 M0 or T2 (tumor no larger than 5 cm) N0 M0, meaning the cancer has not spread to nearby lymph nodes or other parts of the body.
  • Any lymph nodes near your lungs or chest that looked slightly concerning on scans must have tested negative for cancer on biopsy before you can join.
  • You are in reasonably good general health, able to carry out daily activities with little to no limitation (confirmed by your doctor within 4 weeks of joining).
  • You are willing and able to use effective birth control during the trial (applies to both women who could become pregnant and male participants).
  • You have had a physical examination by a radiation oncologist within 4 weeks of joining the trial.
  • You have been evaluated by a chest surgeon before joining the trial.
  • You have had breathing/lung function tests done within 8 weeks of joining the trial.
  • You have had a CT scan of your chest within 6 weeks of joining the trial.
  • You have had a whole-body PET scan within 6 weeks of joining the trial.
  • You have read, understood, and signed the informed consent form.

Who may not be able to join:

  • Your tumor is located in a central part of the lung, close to the main airways in your chest.
  • Your cancer has spread to nearby lymph nodes or to other parts of your body.
  • You have more than one primary lung cancer at the same time.
  • You have been diagnosed with another cancer in the past 2 years, except for certain skin cancers, early-stage (in situ) cancers, or thyroid cancer.
  • You have previously had radiation treatment to your lungs or the area in the middle of your chest.
  • You are planning to receive any other cancer treatments — such as chemotherapy, standard radiation, surgery, or biological therapy — at the same time as this trial.
  • You currently have an active infection in your body, lungs, or around your heart.
  • You are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 585-275-5623

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2018
Est. completion
15 November 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

frequency of grade 3 treatment related toxicities or higher

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov